Q3 2024 Holdings
Filed 2024-11-14 | 62 holdings | $115.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $3.0M | 320,930 | 2.6% |
| Quidelortho Corp | COM | 74838J101 | $3.1M | 67,619 | 2.7% |
| Harrow Health Inc(HROW) | COM | 415858109 | $3.3M | 72,910 | 2.8% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $3.4M | 74,000 | 3.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.5M | 30,240 | 3.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $3.5M | 209,574 | 3.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $3.6M | 10,000 | 3.1% |
| Elutia Inc(ELUT) | COM | 05479K106 | $5.0M | 1,321,215 | 4.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $6.2M | 400,400 | 5.3% |
| Biodesix Inc | COM | 09075X108 | $9.9M | 5,541,176 | 8.6% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $35.5M | 686,182 | 30.8% |